Association between chronic lung allograft dysfunction and human Cytomegalovirus UL40 peptide variants in lung-transplant recipients

JOURNAL OF HEART AND LUNG TRANSPLANTATION

卷:40

Article

Vietzen, Hannes¹  Hartenberger, Svenja¹  Jaksch, Peter²  Puchhammer-Stoeckl, Elisabeth¹ 

[1] Med Univ Vienna, Ctr Virol, Kinderspitalgasse 15, A-1095 Vienna, Austria

[2] Med Univ Vienna, Div Thorac Surg, Vienna, Austria

关键词: CLAD;    human cytomegalovirus;    NK cells;    NKG2C;    UL40;   

DOI  :  10.1016/j.healun.2021.05.011

来源: Elsevier

【 摘 要 】

Natural-Killer cells play an important role in the pathogenesis of chronic lung allograft dysfunction (CLAD) in lung-transplant recipients. Activating NKG2C+ and inhibitory NKG2A+ NK cells proliferate in response to human Cytomegalovirus (HCMV) infection via the presentation of virally encoded UL40 peptides on HLA-E molecules. We aimed to clarify whether infection with HCMV strains carrying different UL40 peptide variants is associated with the development of CLAD. We included 82 lung-transplant recipients, 18 patients developing CLAD and 64 matched control patients without CLAD. In all patients 1 episode of high-level HCMV-replication occurred. HCMV UL40 variants and Natural-Killer-cell proliferation with distinct UL40 peptides were assessed. The VMTPRTLIL variant was significantly overrepresented in patients developing CLAD (p < 0.0001) and lead to a significantly lower proliferation of inhibitory NKG2A+ cells, compared to the VMAPRTLIL, VMAPRTLVL and VMAPRTLLL variants (p < 0.0001). Thus, HCMV UL40 variants may contribute to development of CLAD over the NK cell response. J Heart Lung Transplant 2021;40:900-904 (c) 2021 The Author(s). Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)

【 授权许可】

Free